Metformin is an indirect AMP‐activated protein kinase (AMPK) activator and is currently used for treating equine metabolic syndrome, however, studies suggest that the activation of AMPK may be protective against AF. This evidence concerns the gene PRKAA2 and metabolic syndrome.